Drugs / imipenem/cilastatin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00236834 | Dec 1997 → Jun 2001 | bacterial pneumonia | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | imipenem/cilastatin | “The goal of this study was to compare the efficacy and safety of levofloxacin 750 mg and imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia.” PMID 12749509 ↗ Feb 2003 |
| Route | Intravenous | “imipenem/cilastatin 500 mg to 1 g i.v. every 6 to 8 hours” PMID 12749509 ↗ Feb 2003 |